Breast cancer screening: conflicting guidelines and medicolegal risk.


THERE IS CONSIDERABLE INCONSISTENCY AND CONTROversy in today’s guidelines regarding breast cancer screening. Although the presence of a wide range of professionally endorsed options arguably gives physicians a broader set of clinically valid choices, these options may paradoxically leave clinicians feeling more exposed to claims of malpractice. Consider the… (More)
DOI: 10.1001/jama.2013.7100


Blog articles referencing this paper